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Dear Editor,
Repeated stimulation of T cells results in senescence and
differentiation, which correlates with the loss of co-
stimulatory molecules CD28 and CD27. Highly differen-
tiated CD8þCD28CD27 T cells can display functional
defects, and their increase during ageing may explain the
decreased efficiency of the immune system in older
humans.1 CD8þ T cells can also be separated on the
expression of CD45RA and CD27 molecules into four
populations, each showing progressive features of differ-
entiation and ageing (Figure 1a). Highly differentiated
effector memory (EM) and EM re-expressing CD45RA
(EMRA) CD8þ T cells are largely CD28CD27 , and
accumulate in older humans and in patients with persistent
viral infections and inflammatory syndromes such as
rheumatoid arthritis.1,2
CD28CD27 T cells show the shortest telomeres and
lack of telomerase activity, impaired IL-2 production and
proliferation that correlates with a defective AKT signalling
controlled by the inhibitory receptor KLRG1 and other
inhibitory molecules.3 Indeed AKT controls CD8þ T-cell
growth and gene expression determining memory versus
effector CD8þ T-cell fate and trafficking patterns.4 We here
examine the molecular changes relevant to the defective AKT
pathway that we have previously observed in highly differen-
tiated CD8þ T cells.1,3
HSP90 is a molecular chaperone essential for the stability
of nascent client proteins involved in signal pathways
controlling cell physiology. Impairment of HSP90 in T cells
has been shown to block proliferation, IL-2 secretion and IL-2
receptor expression.5 It is also essential for the correct
assembly of the telomerase holoenzyme and for the interac-
tion of the catalytic subunit hTERT with AKT, critical for
telomerase activation.6
We observed a gradual decline of RICTOR (an essential
component of mTORC2 complex responsible for AKT
phosphorylation at Ser473) and HSP90 as CD8þ T cells
progress towards terminal differentiation (Figure 1b).
A reduced interaction of AKT with either RICTOR or HSP90
was observed in highly differentiated CD28CD27 CD8þ T
cells as a result of the reduced expression of both the
mTORC2 component and the chaperone (Figure 1b). This
contributes to explain the reduced activation of AKT observed
in highly differentiated T cells. Interaction between activated
AKT, hTERT and HSP90 is required for hTERT phosphoryla-
tion and its nuclear import.6 Also, such interaction was
reduced in CD28CD27 T cells (Figure 1b). AKT is highly
dependent on HSP90 for stability and to prevent proteasome-
mediated degradation.7 Absence of phosphorylation by
mTORC2 makes the decreased levels of HSP90 observed
in highly differentiated T cells even more critical for AKT
function and stability. This role was demonstrated by blocking
HSP90 with geldanamycin in undifferentiated CD8þCD28þ T
cells, which resulted in the decline of AKT activation and the
impairment of hTERT stability and its nuclear import in this
subset (Figure 1b). Reduced HSP90 and pSer473-AKT were
also found in highly differentiated CD8þ T cells separated by
CD45RA and CD27-based isolation (Figure 1c).
Our results show for the first time a defect in HSP90
expression in highly differentiated CD8þ T cells, thus
providing new insights about the possible critical role of the
chaperone in the defective functionality of senescent T cells.
The decline of HSP90 may contribute to the reduced
proliferation, IL-2 production and telomerase activity of these
cells. HSP90 impairment has recently been associated with
the loss of CD28molecule in lymphocytes.8 Therefore the loss
of HSP90 can directly contribute to the shaping of a
differentiated phenotype in CD8þ T cells. The identification
of biochemical changes in end-stage differentiated CD8þ T
cells can provide new molecular targets in order to preserve
the replicative capacity and functionality of CD8þ T cells in old
individuals and in models of immune senescence.
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Figure 1 Signalling defects in highly differentiated CD8þ T cells. Buffy Coat samples were obtained from the Transfusion Center of University of Rome ‘Tor Vergata’.
T-cell subsets were isolated according to the expression of the co-stimulatory molecules CD28 and CD27 using Miltenyi Biotec microbeads (Auburn, CA, USA) and activated
with anti-CD3 antibody, Ab (purified OKT3 0.5mg/ml), in the presence or absence of rhIL-2 (5 ng/ml, R&D systems, Minneapolis, MN, USA) at 37 1C in a humidified 5% CO2
incubator. CD45RA/27-based populations were obtained by labeling CD8þ T cells with conjugated anti-CD27 and CD45RA Abs (BD Biosciences, San Jose, CA, USA) and
sorting populations using a FACSAria (BD Biosciences). This separation gives four populations with progressive features in terms of differentiation and ageing, with naive cells
being CD27þ /CD45RAþ , central memory CD27þ /CD45RA , effector memory CD27 /CD45RA and highly differentiated effector memory (EM)-like phenotype (EMRA)
that re-express the CD45RA molecule. Abs used for western blot analysis were from Cell Signalling (Danvers, MA, USA) and Santa Cruz Biotechnology (Dallas, TX, USA). The
quality of extracts and loading control was tested by probing membranes with anti-GAPDH and anti-Histone H1 Abs for cytoplasmic and nuclear extracts, respectively.
Cytoplasmic extracts were negative for Histone H1 (data not shown). For co-immunoprecipitation analysis HNGT-cell lysates were immunoprecipitated with anti-AKT1 Ab,
separated by SDS-PAGE, and probed with RICTOR, HSP90 and hTERT Abs. (a) Representative dot plots of the phenotypic analysis of CD28/27 and CD45RA/27 CD8þ
T-cell populations. (b) To achieve full activation, AKT has to be phosphorylated at Ser473 by mammalian target of rapamycin (mTOR) complex 2 (mTORC2). CD28 /27
subpopulation showed impaired RICTOR-AKT signaling activation and HSP90 expression partially reversed by rhIL-2. This result was confirmed by reduced levels of AKT-co-
immunoprecipitated RICTOR, HSP90 and hTERT. Improper function of HSP90 client proteins can be induced by the HSP90 inhibitor geldanamycin (100 nM), which reduced
pSer473-AKT and hTERT nuclear import in naive CD28þ T cells without affecting T-cell viability. (c) Reduced HSP90 and pSer473-AKT levels were found also in highly
differentiated CD8þ T cells separated by CD45 RA and CD27-based isolation
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